{"id":414782,"date":"2021-01-14T08:03:32","date_gmt":"2021-01-14T13:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=414782"},"modified":"2021-01-14T08:03:32","modified_gmt":"2021-01-14T13:03:32","slug":"cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/","title":{"rendered":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>BOTHELL, Wash., Jan.  14, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <strong><br \/>\n          <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ux8TDgInKfMu5gtBbRwGwAULCwiHEIk7qqy86rG2jNWLSiO3njiF0vPLNgbXp28VPWPSZ5JGp1XtxW5fq9AT1kviLVSgkBUgw4KTEIL10c0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n            <u>Cocrystal Pharma, Inc.<\/u><br \/>\n          <\/a><br \/>\n        <\/strong> (Nasdaq: COCP), (\u201cCocrystal\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, announces that its President Sam Lee, Ph.D. will be making a presentation at the virtual 3<sup>rd<\/sup> Annual reimagine Health Research Symposium, University of Arizona College of Medicine, being held January 21, 2021.<\/p>\n<p align=\"justify\">During a presentation titled \u201cApplication of structure-based drug design platform technology for developing broad spectrum COVID-19, influenza, and HCV antivirals,\u201d Dr. Lee will discuss the use of the Company\u2019s platform technology to develop broad-spectrum antiviral inhibitors.<\/p>\n<p align=\"justify\">\u201cWe are delighted to have the opportunity to present Cocrystal\u2019s enabling technology as used for HCV, influenza and COVID-19 drug discovery,\u201d said Dr. Lee. \u201cLast month we announced the selection of a lead compound for further development against coronaviruses, including SARS-CoV-2, as we advance our COVID-19 program.\u201d<\/p>\n<p>\n        <strong>About the reimagine Health Research Symposium<\/strong>\n      <\/p>\n<p align=\"justify\">The 3<sup>rd<\/sup> Annual reimagine Health Research Symposium will focus on current topics in the areas of intervention and prevention of important diseases that are impacting humankind. It will emphasize approaches for a variety of diseases and crises\u2014including COVID-19, cardiovascular disease, cancer, opioid addiction and the need to develop novel antibiotics. Attendees will learn from and engage with leading experts who will present and discuss contemporary treatment and prevention strategies in the areas of drug discovery, vaccine development, addiction management and the use of artificial intelligence, as well as the ethical and social factors contributing to these approaches. The reimagine Health Research Symposium is co-sponsored and planned by the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_3XbLtGjbu-ker-7K9dRlBJ_z7K2c7v3qFv-jXrRNYyNW4AGMHoo20XeF1BYcZ9nBFq4bzQ_B1dVCQL_MyaE0EhxaKZxPU3vHUcMhzsBfGPW5qnCdvnapnq_EMRDJ7qm\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Arizona Biomedical Research Centre<\/u><\/a>, the University of Arizona College of Medicine \u2013 Phoenix <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fWgJpTfupOHIn1yzmAC6EoBOJvDFacBbCqmol1LRO5JJ6C9SgVLUFFJg9h4FGV7AKWakEOlYPtOd8ZK5tbJRm7kWg8pZSE3sPYrClq0rnMhbS3I7cGdZR7sk5ynv8GDgiyMdCeHXJWtiOMuqHhhwTw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Research Office<\/u><\/a> and the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v6bxfzMR1clu7EtTO-cMeqo6d5wY_diZA9iwonmC5V6sg_usd9mPg0HkA4Gh8PgbD70UNUXgQtIQn7YJ3cNHvw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Flinn Foundation<\/u><\/a>. More information about the symposium is available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eNeqNzP7lVajJAKa7qbaaBuOeMTfQ5c75wfns3PwASznZCDwHp3DdubTi60y-D_cClmXkfUJRVt-MOiqILCPs00KKkhkpl8SygjvHmrnaWo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>here<\/u><\/a>.<\/p>\n<p>\n        <strong>About Cocrystal Pharma, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ebXNSIPqaRUovkuy9hsi7Blu-FuIKbCRQJftsuH5A9VQ79QaVhVd1FW8z6KlwQvYxXQ7nwRMcucGOmDjPiKkCfBUPRzrFx_x1WnKi8Vozlk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.cocrystalpharma.com<\/a><\/u>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>LHA Investor Relations<br \/>Jody Cain<br \/>310-691-7100<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BssMfZPBxPF4Vh8qa1mGekAf7wv9caOw72Fm-PL6XosglChj4O1sII8cGcJVjI1UmNDJ_qLiINp8wG-b8b845A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jcain@lhai.com<\/a><\/u><\/p>\n<p align=\"center\"># # #<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/cd43d1ad-2c66-4af1-a7a7-f3f77b2cddf1\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) &#8212; Cocrystal Pharma, Inc. (Nasdaq: COCP), (\u201cCocrystal\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, announces that its President Sam Lee, Ph.D. will be making a presentation at the virtual 3rd Annual reimagine Health Research Symposium, University of Arizona College of Medicine, being held January 21, 2021. During a presentation titled \u201cApplication of structure-based drug design platform technology for developing broad spectrum COVID-19, influenza, and HCV antivirals,\u201d Dr. Lee will discuss the use of the Company\u2019s platform technology to develop broad-spectrum antiviral inhibitors. \u201cWe are delighted to have the opportunity to present &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-414782","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) &#8212; Cocrystal Pharma, Inc. (Nasdaq: COCP), (\u201cCocrystal\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, announces that its President Sam Lee, Ph.D. will be making a presentation at the virtual 3rd Annual reimagine Health Research Symposium, University of Arizona College of Medicine, being held January 21, 2021. During a presentation titled \u201cApplication of structure-based drug design platform technology for developing broad spectrum COVID-19, influenza, and HCV antivirals,\u201d Dr. Lee will discuss the use of the Company\u2019s platform technology to develop broad-spectrum antiviral inhibitors. \u201cWe are delighted to have the opportunity to present &hellip; Continue reading &quot;Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-14T13:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium\",\"datePublished\":\"2021-01-14T13:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/\"},\"wordCount\":380,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/\",\"name\":\"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\",\"datePublished\":\"2021-01-14T13:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk","og_description":"BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) &#8212; Cocrystal Pharma, Inc. (Nasdaq: COCP), (\u201cCocrystal\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, announces that its President Sam Lee, Ph.D. will be making a presentation at the virtual 3rd Annual reimagine Health Research Symposium, University of Arizona College of Medicine, being held January 21, 2021. During a presentation titled \u201cApplication of structure-based drug design platform technology for developing broad spectrum COVID-19, influenza, and HCV antivirals,\u201d Dr. Lee will discuss the use of the Company\u2019s platform technology to develop broad-spectrum antiviral inhibitors. \u201cWe are delighted to have the opportunity to present &hellip; Continue reading \"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-14T13:03:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium","datePublished":"2021-01-14T13:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/"},"wordCount":380,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/","name":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=","datePublished":"2021-01-14T13:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTQ4NyMzOTE4MDQ0IzIwODQyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cocrystal-to-present-at-the-3rd-annual-reimagine-health-research-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=414782"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414782\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=414782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=414782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=414782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}